GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 78 filers reported holding GENERATION BIO CO in Q3 2023. The put-call ratio across all filers is 2.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,379,244 | -31.1% | 8,279,484 | 0.0% | 4.86% | -14.2% |
| Q2 2023 | $45,537,162 | +27.9% | 8,279,484 | 0.0% | 5.67% | +17.6% |
| Q1 2023 | $35,601,781 | +9.4% | 8,279,484 | +0.0% | 4.82% | +23.0% |
| Q4 2022 | $32,535,983 | -26.0% | 8,278,876 | 0.0% | 3.92% | -19.2% |
| Q3 2022 | $43,961,000 | -19.1% | 8,278,876 | 0.0% | 4.85% | -46.6% |
| Q2 2022 | $54,309,000 | -10.6% | 8,278,876 | 0.0% | 9.08% | +18.2% |
| Q1 2022 | $60,767,000 | +3.7% | 8,278,876 | 0.0% | 7.68% | +42.7% |
| Q4 2021 | $58,614,000 | – | 8,278,876 | – | 5.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |